Original Research
Published on 11 Jan 2024
Identification and validation of a prognostic risk-scoring model for AML based on m7G-associated gene clustering
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1301236
- 1,645 views
Type at least 3 characters
1,695 articles
Articles
Case Report
Published on 09 Jan 2024
Ropeginterferon alfa-2b treatment in a young patient with multi-refractory polycythemia vera and double JAK2 gene mutation: a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1338417
- 1,548 views
- 1 citation
Review
Published on 08 Jan 2024
Extracellular vesicles in the Chronic Myeloid Leukemia scenario: an update about the shuttling of disease markers and therapeutic molecules
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1239042
- 1,594 views
Original Research
Published on 05 Jan 2024
Subclassification of B-acute lymphoblastic leukemia according to age, immunophenotype and microenvironment, predicts MRD risk in Mexican children from vulnerable regions
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1304662
- 4,297 views
Original Research
Published on 04 Jan 2024
Simulating neuronal development: exploring potential mechanisms for central nervous system metastasis in acute lymphoblastic leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1331802
- 1,194 views
Brief Research Report
Published on 04 Jan 2024
A germline JAK2 exon12 mutation and a late somatic CALR mutation in a patient with essential thrombocythemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1265022
- 1,389 views
Case Report
Published on 03 Jan 2024
Case report: EBV-positive epithelioid follicular dendritic cell sarcoma with CD30 expression: a highly challenging diagnosis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1321565
- 1,012 views
Review
Published on 20 Dec 2023
Tyrosine Kinase Inhibitors in pediatric chronic myeloid leukemia: a focused review of clinical trials
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1285346
- 2,085 views
Editorial
Published on 19 Dec 2023
Editorial: 50 years of BMT: risk stratification, donor matching and stem cell collection for transplantation
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1321334
- 993 views
Review
Published on 15 Dec 2023
Molecular and clinical aspects relevant for counseling individuals with clonal hematopoiesis of indeterminate potential
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1303785
- 3,888 views
Systematic Review
Published on 14 Dec 2023
Prevalence and prognostic value of baseline sarcopenia in hematologic malignancies: a systematic review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1308544
- 1,170 views
- 1 citation
Editorial
Published on 13 Dec 2023
Editorial: Challenges in peripheral T-cell lymphomas: from biological advances to clinical applicability
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1325170
- 587 views
Case Report
Published on 13 Dec 2023
Co-existence of KMT2A::SEPTIN6 fusion and DIS3 variant in a pediatric case with acute myeloid leukemia: a case report and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1308786
- 1,107 views
- 1 citation
Mini Review
Published on 11 Dec 2023
The complex nature of lncRNA-mediated chromatin dynamics in multiple myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1303677
- 1,590 views
- 1 citation
Original Research
Published on 07 Dec 2023
Patient-reported experiences during and following treatment with belantamab mafodotin for relapsed/refractory multiple myeloma in the DREAMM-2 study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1274659
- 1,629 views
Review
Published on 06 Dec 2023
Deep learning enhances acute lymphoblastic leukemia diagnosis and classification using bone marrow images
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2023.1330977
- 2,634 views
- 1 citation